Previous 10 | Next 10 |
home / stock / dtc:cc / dtc:cc news
Vancouver, British Columbia--(Newsfile Corp. - December 11, 2023) - Defence Therapeutics Inc. (CSE: DTC) (OTC Pink: DTCFF) (FSE: DTC) (" Defence " or the " Company "), one of the leading Canadian biotechnology companies working in the field of immune-oncology is pleased to announce that the U.S. ...
2023-11-14 08:45:50 ET Palm Beach, FL – November 14, 2023 – FinancialNewsMedia.com News Commentary – Oncology drugs include wide range of medications such as targeted therapies, chemotherapy agents, immunotherapies, and hormone therapies to treat cancer. The...
Vancouver, British Columbia--(Newsfile Corp. - November 14, 2023) - Defence Therapeutics Inc. (CSE: DTC) (OTC Pink: DTCFF) (FSE: DTC) (" Defence " or the " Company "), one of the leading Canadian biotechnology companies working in the field of immune-oncology is pleased to announce that it has su...
Vancouver, British Columbia--(Newsfile Corp. - November 7, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a Canadian biopharmaceutical company developing cutting-edge vaccines, therapeutics, and drug delivery technologies aga...
2023-10-25 08:30:32 ET Palm Beach, FL – October 25, 2023 – FinancialNewsMedia.com News Commentary – The R&D for cancer vaccines has been growing in the last few years and is projected to continue through the next decade. A cancer vaccine is used to eithe...
Vancouver, British Columbia--(Newsfile Corp. - October 25, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a leading Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delive...
Vancouver, British Columbia--(Newsfile Corp. - October 18, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies, is...
Vancouver, British Columbia--(Newsfile Corp. - October 17, 2023) - Defence Therapeutics Inc. (CSE: DTC) (" Defence " or the " Company "), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies, is pleased to announce that sys...
Vancouver, British Columbia--(Newsfile Corp. - October 10, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a biotechnology company developing various products for the immune-oncology vaccines and drug delivery technologies, is pleased to...
Vancouver, British Columbia--(Newsfile Corp. - October 6, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies, is ...
News, Short Squeeze, Breakout and More Instantly...
Defence Therapeutics Inc. Class A Company Name:
DTC:CC Stock Symbol:
CNQC Market:
Defence Therapeutics Inc. Class A Website:
Vancouver, British Columbia--(Newsfile Corp. - July 8, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is pleased to announce that it...
Vancouver, British Columbia--(Newsfile Corp. - June 28, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is please to announce that De...
A look at the top 10 most actives in Canada BlackBerry Limited (BB) rose 10.5% to $3.36 on volume of 12,209,225 shares Solstice Gold Corp. (SGC) fell 33.3% to $0.02 on volume of 11,588,936 shares HIGH INTEREST SAVINGS ACCOUNT FUND (HISA) fell 0.3% to $50.01 on volume of 10,628,355 shares ...